(Q42990213)

12 November 2017

Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirin (English)

1 reference

12 November 2017

0 references

1 reference

1 reference

1 reference

6

Kris V Kowdley

1 reference

12 November 2017

Stephen J Rulyak

1

1 reference

12 November 2017

Sue C Eng

2

1 reference

12 November 2017

Keyur Patel

3

1 reference

12 November 2017

John G McHutchison

4

1 reference

12 November 2017

Stuart C Gordon

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

The American Journal of Gastroenterology

12 November 2017

1 reference

12 November 2017

100

1 reference

12 November 2017

2

1 reference

12 November 2017

332-337

1 reference

Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection

12 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41112.X

Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41112.X

Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41112.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41112.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41112.X

Role of iron in T cell activation: Th1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IGG mabs against the transferrin receptor and the iron chelator deferoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41112.X

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41112.X

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41112.X

10.1111/J.1572-0241.2005.41112.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference